3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
41
Cisplatin
38
Paclitaxel
34
Specimen Handling
32
Radiotherapy
27
Magnetic Resonance Spectroscopy
25
Gemcitabine
23
Vinorelbine
15
Etoposide
15
Docetaxel
15
Biopsy
13
Pemetrexed
10
Cyclophosphamide
10
pembrolizumab
9
Taxes
9
Immunoglobulin G
9
Disulfides
9
Platinum
8
1,2-diaminocyclohexaneplatinum II citrate
8
X-Rays
7
Vinblastine
7
Erlotinib Hydrochloride
7
osimertinib
6
durvalumab
6
atezolizumab
6
Nivolumab
6
Irinotecan
6
Ifosfamide
6
Chemotherapy, Adjuvant
6
Celecoxib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NIH
×
Lung Neoplasms
×
Tomography, Spiral Computed
×
Clear all
NCT00047385
2014-05-20
NLST
National Cancer Institute (NCI)
Phase 3
Completed
53,454 enrolled
15 charts